5-Chlorothiophene-2-carboxylic Acid [(<i>S</i>)-2-[2-Methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a Selective and Potent Orally Active Dual Thrombin and Factor Xa Inhibitor

Jérôme Meneyrol(Sanofi (France)), Jean‐Marc Herbert(Sanofi (France)), Sylvie Klieber(Sanofi (France)), Markus Follmann(Bayer (Germany)), J.M. Altenburger(Sanofi (France)), Zsolt Böcskei(Sanofi (France)), L. Millet(Sanofi (France)), C Briot(Sanofi (France)), Herman Schreuder, T. Rousseaux(Sanofi (France)), Gilbert Lassalle(Sanofi (France)), Freddy Sadoun(Sanofi (France)), G. Barre(Sanofi (France)), Paul Schaeffer(Universidad La Salle), Frédéric Petit(Sanofi (France)), Peter Florian(Sanofi (Germany)), Françoise Bono(OSE Immunotherapeutics (France)), Jean-Pascal Hérault(Sanofi (France)), Frédérique Dol(Sanofi (France)), Nathalie Alet(Evotec (United States)), Volkmar Wehner(Sanofi (Germany))
Journal of Medicinal Chemistry
October 31, 2013
Cited by 25


Related Papers